• "What Do You Mean It's Not Cancer?" A Review of Autoimmune and Systemic Inflammatory Diseases Involving the Breast
• A Case of Early Morphea Mimicking Hypopigmented Mycosis Fungoides in a Pediatric Patient
• A case of multiple autoimmune syndrome comprising autoimmune thyroid disease, vitiligo, morphea, and lichen sclerosus
• A case report of Parry-Romberg syndrome
• A Comparison of Clinical, Demographic and Treatment Characteristics of Pediatric-Onset and Adult-Onset Patients Diagnosed With Localized Scleroderma
• A consensus-based electronic medical record template for pediatric morphea patient visits
• A Rare Case of Bullous Morphea Associated with Autoimmune Hepatitis
• ACKR1+ Endothelial Cells Mediate Leukocyte Infiltration and Synergize with SFRP2/ASPN+ Fibroblasts to Promote Skin Fibrosis in Systemic Sclerosis
• An Assessment of Administration Route on MSC-sEV Therapeutic Efficacy
• An online, two-day educational seminar had no impact on disease-specific knowledge in patients with systemic sclerosis
• Antibody status against measles and rubella in juvenile localized scleroderma patients on sDMARDs: a prospective case-control study
• Association of COVID-19 vaccination and anxiety symptoms: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort longitudinal study
• Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program
• Automated anatomical landmark detection on 3D facial images using U-NET-based deep learning algorithm
• Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease: A post hoc analysis from the focuSSced trial
• Beyond very early systemic sclerosis: deciphering pre-scleroderma and its trajectories to open new avenues for preventive medicine
• Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine
• Carcinogenic risk in patients treated with UVA-1 phototherapy: A 5-year retrospective study
• Clinical and ultrasonographic evaluation of efficacy and safety of intralesional injection of autologous platelet-rich plasma in morphea: A comparative case series
• Clinical, Histologic, and Transcriptomic Evaluation of Sequential Fat Grafting for Morphea: A Nonrandomized Controlled Trial
• Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes
• Dacryoadenitis associated with linear scleroderma en coup de sabre: A case report and review of literature
• Damage evaluation of craniofacial localized scleroderma using magnetic resonance imaging
• Dental Implants in 18 Patients with Systemic Scleroderma: A Retrospective Radiographic Analysis Over a 5-Year Period with Focus on Marginal Bone Loss
• Development of Morphea Following Treatment with an ADA Biosimilar: A Case Report
• Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?
• Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single-center experience
• Efficacy of methylprednisolone in very early systemic sclerosis: results of the "Hit hard and early'' randomized controlled trial
• Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review
• Epidemiology of systemic sclerosis in Quebec, Canada: a population-based study
• Esophagus Dilation and Quality of Life in Adults with Scleroderma and Concomitant Obstructive Sleep Apnea
• Evidence for the causal relationship between rheumatoid arthritis and localized scleroderma: a two-sample mendelian randomization study
• Extensive keloidal morphea in a patient with systemic sclerosis
• Extragenital lichen sclerosus et atrophicus-morphea overlap as an initial presentation of genital lichen sclerosus
• Factors associated with physical function among people with systemic sclerosis: a SPIN cohort cross-sectional study
• Global research status of localised scleroderma reported over the period 1993-2022: A 30-year bibliometric analysis
• High-frequency ultrasound evaluation of morphea: Retrospective analytical study
• IGF-II regulates lysyl oxidase propeptide and mediates its effects in part via basic helix-loop-helix E40
• Interferons Dominate Damage and Activity in Juvenile Scleroderma
• International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus Erythematosus
• Intraoral Involvement in Linear Scleroderma En Coup De Sabre: A Case Report
• Investigation of dermal collagen nanostructures in Ehlers-Danlos Syndrome (EDS) patients
• Invited Response on: "Fat Grafting Reduces Skin Hyperpigmentation of Localized Scleroderma Patients: A Prospective Self-controlled Study"
• Juvenile dermatomyositis with scleroderma features - when skin thickening is not systemic sclerosis
• Juvenile eosinophilic fasciitis: a single center case series
• Juvenile localized scleroderma
• Linear discoid lupus erythematous simulating en coup de sabre morphea in a female chronic granulomatous disease carrier
• Linear indurated plaque over the neck
• Linear Morphea in the Context of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Unique Dermatological Manifestation
• Localised scleroderma and ischemic stroke: case report
• Localized scleroderma
• Localized Scleroderma Burden: A Scoping Review Focusing on the Health-Related Quality of Life, Mental Health, and Productivity
• Mass spectrometry -based proteomic analysis of the skin of patients with localized scleroderma
• Measurement equivalence of the English and French versions of the self-efficacy to manage chronic disease scale: a Scleroderma Patient-Centered Intervention Network (SPIN) study
• Moderators of Loneliness Trajectories in People with Systemic Sclerosis During the COVID-19 Pandemic: A SPIN COVID-19 Cohort Longitudinal Study
• Morphea in patients with psoriasis treated with ustekinumab: a scoping review
• Morphea-like discoid lupus erythematosus in a patient with a history of polyacrylamide gel injection: A case report
• Morphea-like lesions after treatment with ustekinumab
• Morphoea presenting histopathologically as mycosis fungoides: an illustrative series of four cases
• MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study
• Naifold capillaroscopy in mixed connective tissue disease patients
• Nephrotic syndrome due to focal segmental glomerulosclerosis complicating scleroderma: a case report
• Nintedanib in systemic sclerosis treatment: a case report
• Nodular (keloidal) scleroderma: A case series of 5 patients
• Nodular/Keloidal Scleroderma with No Systemic Involvement-A Case Report and a Review of the Literature
• Novel multispectral imaging to predict disease progression in pediatric morphea
• Overlap of Scleroderma and Class V Lupus Nephritis: A Rare Autoimmune Confluence
• Perspective to precision medicine in scleroderma
• Phenotypical and biochemical characterization of murine psoriasiform and fibrotic skin disease models in Stabilin-deficient mice
• Postradiogene Morphea
• Pre-scleroderma and new opportunities for preventive medicine
• Proximal weakness and creatine kinase elevation in systemic sclerosis: Clinical correlates, prognosis and functional implications
• Pulmonary arterial hypertension in systemic sclerosis: a national inpatient analysis
• Pulmonary function in Thai patients with systemic sclerosis; a single center 6-year retrospective study
• Quantifying the Need for Specialist Palliative Care Management in Patients With Systemic Sclerosis
• Quantifying the need for specialist palliative care management in systemic sclerosis
• Radiation-induced morphea-an overview
• Raynaud's phenomenon associated with psoriatic arthritis
• Resilience partially mediates the association between perceived social isolation and life satisfaction in people with systemic sclerosis
• Responsiveness to Change of the Morphea Activity Measure in Pediatric Patients
• S2k guideline: Diagnosis and therapy of localized scleroderma
• S2k‐Leitlinie: Diagnostik und Therapie der zirkumskripten Sklerodermie
• Scleroderma
• Scleroderma-like Lesions in a Patient Undergoing Combined Pembrolizumab and Routine Chemotherapy: A Case Report and Literature Review
• Successful therapy of refractory cutaneous morphea with tofacitinib
• Systemic Sclerosis (Scleroderma)
• The association of resilience and positive mental health in systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) cohort cross-sectional study
• The correlation between Helicobacter pylori infection and iron deficiency anemia in women
• The Impact of Radiation Therapy in Patients with Systemic Sclerosis and Head and Neck Cancer
• The role of excimer light in dermatology: a review
• The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution
• The Serological Evidence of Positive Rheumatoid Factor in Morphea Patients and Its Relation to Disease Severity
• The useful forehead, the impaired forehead, but the forehead… repaired!
• Total Synthesis of Cyclosenegalin A
• Tracking Fat Grafts by Magnetic Resonance Imaging: A Comparative Study of Adolescent and Adult Patients with Stable Localized Scleroderma
• Transition to Adult Rheumatology Care: A Disease-Specific Guide
• Treatment Outcomes of Scleroderma With Janus Kinase Inhibitors: A Systematic Review
• Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
• Ultrasonographic Evaluation of Juvenile Localized Scleroderma: Enhancing Objectivity in Diagnosis and Management
• Unusual overlap of systemic sclerosis with Takayasu arteritis